

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.39216480 |
| 2 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.26178071 |
| 3 | neuronal action potential propagation (GO:0019227) | 5.04449671 |
| 4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.85311639 |
| 5 | vocalization behavior (GO:0071625) | 4.81339917 |
| 6 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.74225131 |
| 7 | locomotory exploration behavior (GO:0035641) | 4.69621679 |
| 8 | synaptic vesicle maturation (GO:0016188) | 4.61194685 |
| 9 | synaptic vesicle exocytosis (GO:0016079) | 4.53960195 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.53229897 |
| 11 | glutamate receptor signaling pathway (GO:0007215) | 4.38969464 |
| 12 | protein localization to synapse (GO:0035418) | 4.38862411 |
| 13 | neuron cell-cell adhesion (GO:0007158) | 4.37831362 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.32478224 |
| 15 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.30900029 |
| 16 | synaptic transmission, glutamatergic (GO:0035249) | 4.27563328 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.25377540 |
| 18 | glutamate secretion (GO:0014047) | 4.20133185 |
| 19 | neuron-neuron synaptic transmission (GO:0007270) | 4.16451337 |
| 20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.08127025 |
| 21 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.96635954 |
| 22 | neurotransmitter secretion (GO:0007269) | 3.93627867 |
| 23 | transmission of nerve impulse (GO:0019226) | 3.91673152 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87098472 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.86602547 |
| 26 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.84879356 |
| 27 | gamma-aminobutyric acid transport (GO:0015812) | 3.83883542 |
| 28 | regulation of synaptic vesicle transport (GO:1902803) | 3.83114646 |
| 29 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.82154823 |
| 30 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.81548727 |
| 31 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.80351548 |
| 32 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.75217486 |
| 33 | long-term memory (GO:0007616) | 3.72893151 |
| 34 | negative regulation of cell killing (GO:0031342) | 3.72345215 |
| 35 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.72345215 |
| 36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.66722622 |
| 37 | regulation of postsynaptic membrane potential (GO:0060078) | 3.61497785 |
| 38 | regulation of synapse structural plasticity (GO:0051823) | 3.59548487 |
| 39 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.57330689 |
| 40 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.57266814 |
| 41 | membrane depolarization during action potential (GO:0086010) | 3.57169207 |
| 42 | exploration behavior (GO:0035640) | 3.55181468 |
| 43 | regulation of neurotransmitter secretion (GO:0046928) | 3.52791818 |
| 44 | positive regulation of membrane potential (GO:0045838) | 3.52603834 |
| 45 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.48017481 |
| 46 | regulation of ARF protein signal transduction (GO:0032012) | 3.47701255 |
| 47 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.47026066 |
| 48 | cellular potassium ion homeostasis (GO:0030007) | 3.46386196 |
| 49 | presynaptic membrane assembly (GO:0097105) | 3.45172414 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.44182124 |
| 51 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.43572565 |
| 52 | auditory behavior (GO:0031223) | 3.42785563 |
| 53 | response to auditory stimulus (GO:0010996) | 3.41848226 |
| 54 | presynaptic membrane organization (GO:0097090) | 3.38898794 |
| 55 | sodium ion export (GO:0071436) | 3.37193904 |
| 56 | membrane depolarization (GO:0051899) | 3.36602448 |
| 57 | membrane hyperpolarization (GO:0060081) | 3.36413164 |
| 58 | positive regulation of neurotransmitter transport (GO:0051590) | 3.34773899 |
| 59 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.34409490 |
| 60 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.34394379 |
| 61 | neurotransmitter transport (GO:0006836) | 3.32405148 |
| 62 | prepulse inhibition (GO:0060134) | 3.32135072 |
| 63 | regulation of neurotransmitter transport (GO:0051588) | 3.31692058 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.31630677 |
| 65 | signal complex assembly (GO:0007172) | 3.31537762 |
| 66 | regulation of synaptic plasticity (GO:0048167) | 3.31115172 |
| 67 | synaptic vesicle endocytosis (GO:0048488) | 3.29488898 |
| 68 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.29263451 |
| 69 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.24604870 |
| 70 | macrophage activation involved in immune response (GO:0002281) | 3.24523284 |
| 71 | striatum development (GO:0021756) | 3.24198580 |
| 72 | negative regulation of dendrite development (GO:2000171) | 3.20849411 |
| 73 | neuronal action potential (GO:0019228) | 3.20541779 |
| 74 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.20256099 |
| 75 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.19314297 |
| 76 | postsynaptic membrane organization (GO:0001941) | 3.19038631 |
| 77 | cerebellar granule cell differentiation (GO:0021707) | 3.18482809 |
| 78 | regulation of vesicle fusion (GO:0031338) | 3.17594989 |
| 79 | negative regulation of interleukin-12 production (GO:0032695) | 3.16927243 |
| 80 | adult walking behavior (GO:0007628) | 3.13877020 |
| 81 | learning (GO:0007612) | 3.13871813 |
| 82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.12775772 |
| 83 | mechanosensory behavior (GO:0007638) | 3.12029030 |
| 84 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.10214882 |
| 85 | behavioral response to cocaine (GO:0048148) | 3.09945197 |
| 86 | neuromuscular process controlling balance (GO:0050885) | 3.09415649 |
| 87 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.06426172 |
| 88 | synaptic transmission, dopaminergic (GO:0001963) | 3.06169710 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 3.06063862 |
| 90 | mannose metabolic process (GO:0006013) | 3.03605537 |
| 91 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03029110 |
| 92 | synapse assembly (GO:0007416) | 3.02619083 |
| 93 | neuron recognition (GO:0008038) | 3.02202982 |
| 94 | L-amino acid import (GO:0043092) | 3.01995679 |
| 95 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.01420016 |
| 96 | regulation of neurotransmitter levels (GO:0001505) | 3.00701258 |
| 97 | neuromuscular process controlling posture (GO:0050884) | 2.99678233 |
| 98 | glycine transport (GO:0015816) | 2.98935262 |
| 99 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.98740993 |
| 100 | synaptic transmission (GO:0007268) | 2.98336845 |
| 101 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96920072 |
| 102 | neuronal ion channel clustering (GO:0045161) | 2.96065975 |
| 103 | response to amphetamine (GO:0001975) | 2.95792755 |
| 104 | response to histamine (GO:0034776) | 2.95357628 |
| 105 | positive regulation of synapse maturation (GO:0090129) | 2.94823419 |
| 106 | regulation of synapse maturation (GO:0090128) | 2.92710572 |
| 107 | regulation of respiratory system process (GO:0044065) | 2.92126352 |
| 108 | positive regulation of synaptic transmission (GO:0050806) | 2.91611366 |
| 109 | behavioral fear response (GO:0001662) | 2.90978883 |
| 110 | behavioral defense response (GO:0002209) | 2.90978883 |
| 111 | behavioral response to ethanol (GO:0048149) | 2.90213011 |
| 112 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.89942355 |
| 113 | NIK/NF-kappaB signaling (GO:0038061) | 2.89876236 |
| 114 | proline transport (GO:0015824) | 2.89619032 |
| 115 | fear response (GO:0042596) | 2.87841805 |
| 116 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.87659604 |
| 117 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.84464047 |
| 118 | germinal center formation (GO:0002467) | 2.82163590 |
| 119 | positive regulation of Rap GTPase activity (GO:0032854) | 2.81669628 |
| 120 | protein localization to endosome (GO:0036010) | 2.79364258 |
| 121 | activation of MAPKKK activity (GO:0000185) | 2.73599667 |
| 122 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70748570 |
| 123 | myeloid dendritic cell differentiation (GO:0043011) | 2.64024176 |
| 124 | response to peptidoglycan (GO:0032494) | 2.59741263 |
| 125 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.58636064 |
| 126 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58227886 |
| 127 | regulation of ARF GTPase activity (GO:0032312) | 2.57691697 |
| 128 | type I interferon signaling pathway (GO:0060337) | 2.56545806 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.56545806 |
| 130 | response to type I interferon (GO:0034340) | 2.55478741 |
| 131 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.54742025 |
| 132 | regulation of T cell tolerance induction (GO:0002664) | 2.48943053 |
| 133 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.48706188 |
| 134 | positive thymic T cell selection (GO:0045059) | 2.45803312 |
| 135 | leukocyte aggregation (GO:0070486) | 2.45166481 |
| 136 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.44766181 |
| 137 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.44766181 |
| 138 | modulation by symbiont of host immune response (GO:0052553) | 2.44766181 |
| 139 | positive regulation by symbiont of host defense response (GO:0052509) | 2.44766181 |
| 140 | modulation by symbiont of host defense response (GO:0052031) | 2.44766181 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.44766181 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44611773 |
| 143 | regulation of early endosome to late endosome transport (GO:2000641) | 2.44171440 |
| 144 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.43954736 |
| 145 | regulation of gamma-delta T cell activation (GO:0046643) | 2.43083299 |
| 146 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42848179 |
| 147 | glycosphingolipid catabolic process (GO:0046479) | 2.41981037 |
| 148 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.41826380 |
| 149 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.41364381 |
| 150 | positive regulation of protein dephosphorylation (GO:0035307) | 2.39570077 |
| 151 | adenosine receptor signaling pathway (GO:0001973) | 2.36354231 |
| 152 | neutrophil activation involved in immune response (GO:0002283) | 2.35520687 |
| 153 | T cell migration (GO:0072678) | 2.33802723 |
| 154 | amino acid import (GO:0043090) | 2.33428488 |
| 155 | regulation of Rap GTPase activity (GO:0032317) | 2.33345812 |
| 156 | response to manganese ion (GO:0010042) | 2.33192502 |
| 157 | response to acidic pH (GO:0010447) | 2.29569083 |
| 158 | thymic T cell selection (GO:0045061) | 2.27028911 |
| 159 | regulation of regulated secretory pathway (GO:1903305) | 2.22783707 |
| 160 | response to muramyl dipeptide (GO:0032495) | 2.22292693 |
| 161 | regulation of type 2 immune response (GO:0002828) | 2.22076078 |
| 162 | myeloid cell activation involved in immune response (GO:0002275) | 2.20321325 |
| 163 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.20152685 |
| 164 | negative regulation of type 2 immune response (GO:0002829) | 2.20063073 |
| 165 | glycolipid catabolic process (GO:0019377) | 2.19343365 |
| 166 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.19142671 |
| 167 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.19142115 |
| 168 | regulation of leukocyte degranulation (GO:0043300) | 2.17215951 |
| 169 | T cell selection (GO:0045058) | 2.17010617 |
| 170 | positive regulation of type 2 immune response (GO:0002830) | 2.16944373 |
| 171 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.15572013 |
| 172 | regulation of chronic inflammatory response (GO:0002676) | 2.14569104 |
| 173 | negative regulation of amino acid transport (GO:0051956) | 2.14259021 |
| 174 | positive T cell selection (GO:0043368) | 2.12021825 |
| 175 | myeloid dendritic cell activation (GO:0001773) | 2.11764483 |
| 176 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.11561059 |
| 177 | adhesion of symbiont to host cell (GO:0044650) | 2.11126719 |
| 178 | virion attachment to host cell (GO:0019062) | 2.11126719 |
| 179 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.10026413 |
| 180 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.09805195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.37330812 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.91969586 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.30604343 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05039052 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.03512840 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96153595 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65432796 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65432796 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.60203718 |
| 10 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55404433 |
| 11 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.52808326 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52176053 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.49026123 |
| 14 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.48273130 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48070356 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.42219068 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38726955 |
| 18 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34787251 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.33536565 |
| 20 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33127959 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32507668 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29862851 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.28945853 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23485440 |
| 25 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.16985471 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.16071184 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15919194 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05259560 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01248235 |
| 30 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99404667 |
| 31 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.97151440 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96955038 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.96570478 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.90563323 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89602113 |
| 36 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.89181625 |
| 37 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.89179099 |
| 38 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88889680 |
| 39 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.88421383 |
| 40 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88073654 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.85775729 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.85689175 |
| 43 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.85336415 |
| 44 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85296987 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83992858 |
| 46 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.82168170 |
| 47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.81015766 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77992912 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.75996569 |
| 50 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.73609310 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73219318 |
| 52 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.70300847 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69657387 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69131036 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69100800 |
| 56 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.68712135 |
| 57 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68493353 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.68390888 |
| 59 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.67270749 |
| 60 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.65892571 |
| 61 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65842900 |
| 62 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65010776 |
| 63 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.64424772 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.63485598 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.62346836 |
| 66 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.61861586 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60202600 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.57058268 |
| 69 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.56857211 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.50978544 |
| 71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.50974090 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49834497 |
| 73 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.48900512 |
| 74 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48066855 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.47492170 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.46421180 |
| 77 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46324609 |
| 78 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43822346 |
| 79 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40913359 |
| 80 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.40843372 |
| 81 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.40730188 |
| 82 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40244578 |
| 83 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38081563 |
| 84 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37471615 |
| 85 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.37241995 |
| 86 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37083932 |
| 87 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37048003 |
| 88 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.34886840 |
| 89 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.33817155 |
| 90 | STAT3_23295773_ChIP-Seq_U87_Human | 1.33238392 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33222404 |
| 92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.32472785 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.31814335 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31765160 |
| 95 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.31537423 |
| 96 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.31347802 |
| 97 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30590239 |
| 98 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.29961308 |
| 99 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.29091228 |
| 100 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.27796217 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 1.27520692 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27237698 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27002599 |
| 104 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26236404 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26070412 |
| 106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25194904 |
| 107 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25054578 |
| 108 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24256794 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.23708525 |
| 110 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23082374 |
| 111 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23004321 |
| 112 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22917338 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.22579409 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21324890 |
| 115 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20866791 |
| 116 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.20419430 |
| 117 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19343923 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17929461 |
| 119 | MYC_22102868_ChIP-Seq_BL_Human | 1.17714335 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17599320 |
| 121 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17577820 |
| 122 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16575345 |
| 123 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16381054 |
| 124 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.15655185 |
| 125 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15596323 |
| 126 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15354148 |
| 127 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13830292 |
| 128 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13438875 |
| 129 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.13353003 |
| 130 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.13094689 |
| 131 | * AR_19668381_ChIP-Seq_PC3_Human | 1.12876994 |
| 132 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.11577428 |
| 133 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.11255100 |
| 134 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11255100 |
| 135 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10692967 |
| 136 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10128633 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09744636 |
| 138 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09728350 |
| 139 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09718745 |
| 140 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09532276 |
| 141 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.09375428 |
| 142 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.09065104 |
| 143 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.09010203 |
| 144 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08924699 |
| 145 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08567077 |
| 146 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08510254 |
| 147 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.08313976 |
| 148 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.07568590 |
| 149 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.07399749 |
| 150 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07115878 |
| 151 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06570218 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.06298225 |
| 153 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06297057 |
| 154 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06144451 |
| 155 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05207768 |
| 156 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04464472 |
| 157 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04429180 |
| 158 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.02753303 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02636870 |
| 160 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.02633952 |
| 161 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.02143680 |
| 162 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01915462 |
| 163 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01486988 |
| 164 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01237129 |
| 165 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.00864880 |
| 166 | FUS_26573619_Chip-Seq_HEK293_Human | 1.00593343 |
| 167 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00545948 |
| 168 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98854898 |
| 169 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98645430 |
| 170 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.98304475 |
| 171 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97888260 |
| 172 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97806520 |
| 173 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97423141 |
| 174 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97367291 |
| 175 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97321874 |
| 176 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.96704890 |
| 177 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95858183 |
| 178 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95830908 |
| 179 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.95430249 |
| 180 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95121298 |
| 181 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95051323 |
| 182 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95046749 |
| 183 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.95000907 |
| 184 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.94750370 |
| 185 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.94584467 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.29192820 |
| 2 | MP0003880_abnormal_central_pattern | 4.33761838 |
| 3 | MP0003303_peritoneal_inflammation | 3.78572538 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.72202016 |
| 5 | MP0002822_catalepsy | 3.68482859 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.56424722 |
| 7 | MP0004270_analgesia | 3.46758765 |
| 8 | MP0009046_muscle_twitch | 3.42876900 |
| 9 | MP0009745_abnormal_behavioral_response | 3.37672938 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.15132297 |
| 11 | MP0005058_abnormal_lysosome_morphology | 3.08351707 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.98311721 |
| 13 | MP0002064_seizures | 2.98123404 |
| 14 | MP0006082_CNS_inflammation | 2.96817597 |
| 15 | MP0002736_abnormal_nociception_after | 2.95771442 |
| 16 | MP0003436_decreased_susceptibility_to | 2.95486942 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.84570982 |
| 18 | MP0002272_abnormal_nervous_system | 2.83597537 |
| 19 | MP0002734_abnormal_mechanical_nocicepti | 2.83290955 |
| 20 | MP0001486_abnormal_startle_reflex | 2.79399549 |
| 21 | MP0002572_abnormal_emotion/affect_behav | 2.71825907 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.60885759 |
| 23 | MP0003724_increased_susceptibility_to | 2.36452767 |
| 24 | MP0009840_abnormal_foam_cell | 2.30364697 |
| 25 | MP0003075_altered_response_to | 2.20923755 |
| 26 | MP0002067_abnormal_sensory_capabilities | 2.20895759 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.18762302 |
| 28 | MP0005671_abnormal_response_to | 2.15888309 |
| 29 | MP0001970_abnormal_pain_threshold | 2.15507840 |
| 30 | MP0000604_amyloidosis | 2.14534367 |
| 31 | MP0002733_abnormal_thermal_nociception | 2.12956427 |
| 32 | MP0001188_hyperpigmentation | 2.08856466 |
| 33 | MP0005000_abnormal_immune_tolerance | 2.08281916 |
| 34 | MP0003300_gastrointestinal_ulcer | 2.07287650 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 1.98893508 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.97317478 |
| 37 | MP0008569_lethality_at_weaning | 1.96482380 |
| 38 | MP0002419_abnormal_innate_immunity | 1.91161091 |
| 39 | MP0001790_abnormal_immune_system | 1.89616531 |
| 40 | MP0005387_immune_system_phenotype | 1.89616531 |
| 41 | MP0002184_abnormal_innervation | 1.88594162 |
| 42 | MP0009785_altered_susceptibility_to | 1.85541855 |
| 43 | MP0004947_skin_inflammation | 1.85505060 |
| 44 | MP0001984_abnormal_olfaction | 1.85492339 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.83942495 |
| 46 | MP0005025_abnormal_response_to | 1.83246921 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.78621011 |
| 48 | MP0005451_abnormal_body_composition | 1.78125525 |
| 49 | MP0005646_abnormal_pituitary_gland | 1.77265438 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.76811413 |
| 51 | MP0003191_abnormal_cellular_cholesterol | 1.69940518 |
| 52 | MP0003787_abnormal_imprinting | 1.69150855 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.64237435 |
| 54 | MP0004924_abnormal_behavior | 1.64237435 |
| 55 | MP0005551_abnormal_eye_electrophysiolog | 1.61354673 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.60231072 |
| 57 | MP0002723_abnormal_immune_serum | 1.60029191 |
| 58 | MP0000778_abnormal_nervous_system | 1.59318070 |
| 59 | MP0005166_decreased_susceptibility_to | 1.58237620 |
| 60 | MP0001800_abnormal_humoral_immune | 1.53000393 |
| 61 | MP0001529_abnormal_vocalization | 1.52387572 |
| 62 | MP0005645_abnormal_hypothalamus_physiol | 1.50284909 |
| 63 | MP0004142_abnormal_muscle_tone | 1.49082768 |
| 64 | MP0004742_abnormal_vestibular_system | 1.48644057 |
| 65 | MP0004811_abnormal_neuron_physiology | 1.47337503 |
| 66 | MP0001986_abnormal_taste_sensitivity | 1.46842879 |
| 67 | MP0002452_abnormal_antigen_presenting | 1.46494108 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.46135615 |
| 69 | MP0009333_abnormal_splenocyte_physiolog | 1.45677849 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.44094982 |
| 71 | MP0003879_abnormal_hair_cell | 1.43782117 |
| 72 | MP0005409_darkened_coat_color | 1.43540281 |
| 73 | MP0002882_abnormal_neuron_morphology | 1.42106668 |
| 74 | MP0000955_abnormal_spinal_cord | 1.41895533 |
| 75 | MP0010155_abnormal_intestine_physiology | 1.41266427 |
| 76 | MP0004858_abnormal_nervous_system | 1.41189883 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.39647418 |
| 78 | MP0001819_abnormal_immune_cell | 1.38615574 |
| 79 | MP0001905_abnormal_dopamine_level | 1.37652087 |
| 80 | MP0002638_abnormal_pupillary_reflex | 1.36835407 |
| 81 | MP0003763_abnormal_thymus_physiology | 1.35411012 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 1.32794236 |
| 83 | MP0006292_abnormal_olfactory_placode | 1.29935802 |
| 84 | MP0003453_abnormal_keratinocyte_physiol | 1.29203242 |
| 85 | MP0005310_abnormal_salivary_gland | 1.28730531 |
| 86 | MP0000343_altered_response_to | 1.28288854 |
| 87 | MP0001502_abnormal_circadian_rhythm | 1.26918254 |
| 88 | MP0009278_abnormal_bone_marrow | 1.25553175 |
| 89 | MP0000685_abnormal_immune_system | 1.22626512 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.22604908 |
| 91 | MP0001348_abnormal_lacrimal_gland | 1.21834796 |
| 92 | MP0003633_abnormal_nervous_system | 1.20840985 |
| 93 | MP0004885_abnormal_endolymph | 1.19778292 |
| 94 | MP0002405_respiratory_system_inflammati | 1.18660446 |
| 95 | MP0005171_absent_coat_pigmentation | 1.14537484 |
| 96 | MP0010386_abnormal_urinary_bladder | 1.14439298 |
| 97 | MP0002229_neurodegeneration | 1.13781421 |
| 98 | MP0002332_abnormal_exercise_endurance | 1.10839488 |
| 99 | MP0001873_stomach_inflammation | 1.09059977 |
| 100 | MP0008004_abnormal_stomach_pH | 1.08868974 |
| 101 | MP0001963_abnormal_hearing_physiology | 1.08539816 |
| 102 | MP0003045_fibrosis | 1.08261502 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 1.08157769 |
| 104 | MP0008872_abnormal_physiological_respon | 1.08112178 |
| 105 | MP0009764_decreased_sensitivity_to | 1.07565584 |
| 106 | MP0004145_abnormal_muscle_electrophysio | 1.04769743 |
| 107 | MP0001853_heart_inflammation | 1.04615665 |
| 108 | MP0003631_nervous_system_phenotype | 1.04338679 |
| 109 | MP0002752_abnormal_somatic_nervous | 1.03505485 |
| 110 | MP0008469_abnormal_protein_level | 1.03062878 |
| 111 | MP0002909_abnormal_adrenal_gland | 1.02234808 |
| 112 | MP0003136_yellow_coat_color | 1.01748503 |
| 113 | MP0003448_altered_tumor_morphology | 1.00897220 |
| 114 | MP0001485_abnormal_pinna_reflex | 1.00776295 |
| 115 | MP0000716_abnormal_immune_system | 0.97937182 |
| 116 | MP0005499_abnormal_olfactory_system | 0.97766958 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.97766958 |
| 118 | MP0000920_abnormal_myelination | 0.97544563 |
| 119 | MP0000015_abnormal_ear_pigmentation | 0.96086858 |
| 120 | MP0002152_abnormal_brain_morphology | 0.95722187 |
| 121 | MP0009780_abnormal_chondrocyte_physiolo | 0.95326230 |
| 122 | MP0003866_abnormal_defecation | 0.92826045 |
| 123 | MP0001851_eye_inflammation | 0.91318915 |
| 124 | MP0005464_abnormal_platelet_physiology | 0.90983424 |
| 125 | MP0003091_abnormal_cell_migration | 0.89869514 |
| 126 | MP0005253_abnormal_eye_physiology | 0.87683985 |
| 127 | MP0002933_joint_inflammation | 0.86441400 |
| 128 | MP0003329_amyloid_beta_deposits | 0.85034648 |
| 129 | MP0000858_altered_metastatic_potential | 0.84285153 |
| 130 | MP0003705_abnormal_hypodermis_morpholog | 0.83806289 |
| 131 | MP0006072_abnormal_retinal_apoptosis | 0.82344059 |
| 132 | MP0001545_abnormal_hematopoietic_system | 0.82028476 |
| 133 | MP0005397_hematopoietic_system_phenotyp | 0.82028476 |
| 134 | MP0002398_abnormal_bone_marrow | 0.81790700 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.81345224 |
| 136 | MP0001177_atelectasis | 0.80352518 |
| 137 | MP0008874_decreased_physiological_sensi | 0.79665139 |
| 138 | MP0005165_increased_susceptibility_to | 0.79285517 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.79089830 |
| 140 | MP0003690_abnormal_glial_cell | 0.77218291 |
| 141 | MP0000631_abnormal_neuroendocrine_gland | 0.76950067 |
| 142 | MP0001849_ear_inflammation | 0.75433291 |
| 143 | MP0003632_abnormal_nervous_system | 0.74645650 |
| 144 | MP0000026_abnormal_inner_ear | 0.74628839 |
| 145 | MP0003634_abnormal_glial_cell | 0.74163797 |
| 146 | MP0002090_abnormal_vision | 0.72070647 |
| 147 | MP0001765_abnormal_ion_homeostasis | 0.71932861 |
| 148 | MP0003279_aneurysm | 0.71169810 |
| 149 | MP0005666_abnormal_adipose_tissue | 0.67965941 |
| 150 | MP0004085_abnormal_heartbeat | 0.67148168 |
| 151 | MP0001663_abnormal_digestive_system | 0.66401484 |
| 152 | MP0005535_abnormal_body_temperature | 0.61114132 |
| 153 | MP0002751_abnormal_autonomic_nervous | 0.60508225 |
| 154 | MP0002876_abnormal_thyroid_physiology | 0.59977465 |
| 155 | MP0001664_abnormal_digestion | 0.59323187 |
| 156 | MP0002102_abnormal_ear_morphology | 0.54273990 |
| 157 | MP0008260_abnormal_autophagy | 0.53917247 |
| 158 | MP0008877_abnormal_DNA_methylation | 0.51835938 |
| 159 | MP0003137_abnormal_impulse_conducting | 0.50437647 |
| 160 | MP0001943_abnormal_respiration | 0.49607016 |
| 161 | MP0000751_myopathy | 0.48321140 |
| 162 | MP0005195_abnormal_posterior_eye | 0.48277669 |
| 163 | MP0005167_abnormal_blood-brain_barrier | 0.47563275 |
| 164 | MP0004510_myositis | 0.47321299 |
| 165 | MP0010769_abnormal_survival | 0.46372745 |
| 166 | MP0004147_increased_porphyrin_level | 0.46117713 |
| 167 | MP0002082_postnatal_lethality | 0.45916637 |
| 168 | MP0010770_preweaning_lethality | 0.45916637 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.67592023 |
| 2 | Myokymia (HP:0002411) | 6.64265156 |
| 3 | Febrile seizures (HP:0002373) | 5.62672641 |
| 4 | Focal seizures (HP:0007359) | 5.57771367 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.90014193 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.78743315 |
| 7 | Action tremor (HP:0002345) | 4.59552920 |
| 8 | Atonic seizures (HP:0010819) | 4.49521988 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.48002727 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.48002727 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.48002727 |
| 12 | Neurofibrillary tangles (HP:0002185) | 4.32763584 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 4.05410363 |
| 14 | Visual hallucinations (HP:0002367) | 3.94044524 |
| 15 | Broad-based gait (HP:0002136) | 3.76592195 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.67972373 |
| 17 | Absence seizures (HP:0002121) | 3.60849140 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.52879339 |
| 19 | Generalized tonic-clonic seizures (HP:0002069) | 3.51267992 |
| 20 | Eczematoid dermatitis (HP:0000976) | 3.48329986 |
| 21 | Dialeptic seizures (HP:0011146) | 3.46784139 |
| 22 | Neuronal loss in central nervous system (HP:0002529) | 3.40971151 |
| 23 | Increased cerebral lipofuscin (HP:0011813) | 3.40678705 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.36959276 |
| 25 | Loss of speech (HP:0002371) | 3.31226380 |
| 26 | Obstructive sleep apnea (HP:0002870) | 3.31111772 |
| 27 | Dysdiadochokinesis (HP:0002075) | 3.17650064 |
| 28 | Nuclear cataract (HP:0100018) | 3.12971737 |
| 29 | Systemic lupus erythematosus (HP:0002725) | 3.02995409 |
| 30 | Scanning speech (HP:0002168) | 2.96362870 |
| 31 | Congenital stationary night blindness (HP:0007642) | 2.94057621 |
| 32 | Poor eye contact (HP:0000817) | 2.93618883 |
| 33 | Axonal loss (HP:0003447) | 2.89198265 |
| 34 | Dysmetria (HP:0001310) | 2.88353784 |
| 35 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.87435710 |
| 36 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.87435710 |
| 37 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.87435710 |
| 38 | Mucopolysacchariduria (HP:0008155) | 2.85753766 |
| 39 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85753766 |
| 40 | Hyperventilation (HP:0002883) | 2.82255359 |
| 41 | Supranuclear gaze palsy (HP:0000605) | 2.81457181 |
| 42 | Apathy (HP:0000741) | 2.80605759 |
| 43 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.79860580 |
| 44 | Myositis (HP:0100614) | 2.78860891 |
| 45 | Truncal ataxia (HP:0002078) | 2.77765094 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.76151554 |
| 47 | Orchitis (HP:0100796) | 2.74835048 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.73635737 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73533784 |
| 50 | Papilledema (HP:0001085) | 2.72832479 |
| 51 | Recurrent abscess formation (HP:0002722) | 2.70728475 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.66881128 |
| 53 | Amblyopia (HP:0000646) | 2.66464664 |
| 54 | Hemiparesis (HP:0001269) | 2.62806680 |
| 55 | Disinhibition (HP:0000734) | 2.62389321 |
| 56 | Ulnar claw (HP:0001178) | 2.61527079 |
| 57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.60737116 |
| 58 | Diminished motivation (HP:0000745) | 2.60622967 |
| 59 | Ankle clonus (HP:0011448) | 2.60588946 |
| 60 | Retrobulbar optic neuritis (HP:0100654) | 2.56892439 |
| 61 | Optic neuritis (HP:0100653) | 2.56892439 |
| 62 | Anxiety (HP:0000739) | 2.56511877 |
| 63 | Fetal akinesia sequence (HP:0001989) | 2.54955872 |
| 64 | Stomatitis (HP:0010280) | 2.54141175 |
| 65 | Tetraplegia (HP:0002445) | 2.53505778 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.53038171 |
| 67 | Abnormal eating behavior (HP:0100738) | 2.48214593 |
| 68 | Abnormality of binocular vision (HP:0011514) | 2.48075827 |
| 69 | Diplopia (HP:0000651) | 2.48075827 |
| 70 | Absent speech (HP:0001344) | 2.46237454 |
| 71 | Depression (HP:0000716) | 2.42736939 |
| 72 | Absent/shortened dynein arms (HP:0200106) | 2.41229260 |
| 73 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.41229260 |
| 74 | Abnormal social behavior (HP:0012433) | 2.39576726 |
| 75 | Impaired social interactions (HP:0000735) | 2.39576726 |
| 76 | Genetic anticipation (HP:0003743) | 2.36270422 |
| 77 | Stereotypic behavior (HP:0000733) | 2.35343912 |
| 78 | Spastic gait (HP:0002064) | 2.29853645 |
| 79 | Gait imbalance (HP:0002141) | 2.29478493 |
| 80 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.27267118 |
| 81 | Interstitial pulmonary disease (HP:0006530) | 2.25474052 |
| 82 | Dementia (HP:0000726) | 2.25268820 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.24701311 |
| 84 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24316079 |
| 85 | Progressive inability to walk (HP:0002505) | 2.16616029 |
| 86 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.16353443 |
| 87 | Hemiplegia (HP:0002301) | 2.16094805 |
| 88 | Medial flaring of the eyebrow (HP:0010747) | 2.14591287 |
| 89 | Limb dystonia (HP:0002451) | 2.13568318 |
| 90 | Autoimmune thrombocytopenia (HP:0001973) | 2.12279150 |
| 91 | Delusions (HP:0000746) | 2.12038209 |
| 92 | Annular pancreas (HP:0001734) | 2.11832563 |
| 93 | Excessive salivation (HP:0003781) | 2.11040382 |
| 94 | Drooling (HP:0002307) | 2.11040382 |
| 95 | Congenital primary aphakia (HP:0007707) | 2.10501147 |
| 96 | Abnormality of the corticospinal tract (HP:0002492) | 2.09748882 |
| 97 | Rigidity (HP:0002063) | 2.09309213 |
| 98 | J-shaped sella turcica (HP:0002680) | 2.08681695 |
| 99 | Amyloidosis (HP:0011034) | 2.08531218 |
| 100 | Abnormal ciliary motility (HP:0012262) | 2.05928047 |
| 101 | Rapidly progressive (HP:0003678) | 2.05919436 |
| 102 | Postural instability (HP:0002172) | 2.05191016 |
| 103 | Inability to walk (HP:0002540) | 2.03116725 |
| 104 | Memory impairment (HP:0002354) | 2.02251348 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99197828 |
| 106 | Urinary urgency (HP:0000012) | 1.98325271 |
| 107 | Intention tremor (HP:0002080) | 1.98224793 |
| 108 | Protruding tongue (HP:0010808) | 1.97325033 |
| 109 | Mutism (HP:0002300) | 1.97092546 |
| 110 | Status epilepticus (HP:0002133) | 1.96234186 |
| 111 | Impaired vibratory sensation (HP:0002495) | 1.95774206 |
| 112 | Ocular albinism (HP:0001107) | 1.95749208 |
| 113 | Distal upper limb amyotrophy (HP:0007149) | 1.95635822 |
| 114 | Upper limb amyotrophy (HP:0009129) | 1.95635822 |
| 115 | Asymmetric septal hypertrophy (HP:0001670) | 1.95425556 |
| 116 | Torticollis (HP:0000473) | 1.94698133 |
| 117 | Abnormality of the periventricular white matter (HP:0002518) | 1.94193175 |
| 118 | Dysmetric saccades (HP:0000641) | 1.93139956 |
| 119 | Gingivitis (HP:0000230) | 1.92779824 |
| 120 | Hyperparathyroidism (HP:0000843) | 1.92114255 |
| 121 | Specific learning disability (HP:0001328) | 1.91924192 |
| 122 | Blue irides (HP:0000635) | 1.91133919 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 1.90725475 |
| 124 | Personality changes (HP:0000751) | 1.90675092 |
| 125 | Incomplete penetrance (HP:0003829) | 1.90641820 |
| 126 | Central scotoma (HP:0000603) | 1.90639566 |
| 127 | Abnormality of the nasal mucosa (HP:0000433) | 1.90604397 |
| 128 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90555369 |
| 129 | Obstructive lung disease (HP:0006536) | 1.88212497 |
| 130 | Chronic obstructive pulmonary disease (HP:0006510) | 1.88212497 |
| 131 | Peripheral hypomyelination (HP:0007182) | 1.88149006 |
| 132 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.88138358 |
| 133 | Purpura (HP:0000979) | 1.87568031 |
| 134 | Pulmonary infiltrates (HP:0002113) | 1.87516402 |
| 135 | Termporal pattern (HP:0011008) | 1.87504026 |
| 136 | Insidious onset (HP:0003587) | 1.87504026 |
| 137 | Malnutrition (HP:0004395) | 1.86657306 |
| 138 | Cerebral aneurysm (HP:0004944) | 1.86486556 |
| 139 | Ventricular fibrillation (HP:0001663) | 1.85304285 |
| 140 | Epileptiform EEG discharges (HP:0011182) | 1.85033341 |
| 141 | Global brain atrophy (HP:0002283) | 1.84980830 |
| 142 | Focal dystonia (HP:0004373) | 1.83971475 |
| 143 | Abnormal hair whorl (HP:0010721) | 1.83641477 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.83486946 |
| 145 | Stridor (HP:0010307) | 1.83142261 |
| 146 | Abnormal EKG (HP:0003115) | 1.81457908 |
| 147 | Genital tract atresia (HP:0001827) | 1.80616537 |
| 148 | Increased CSF protein (HP:0002922) | 1.80225928 |
| 149 | Deeply set eye (HP:0000490) | 1.78701148 |
| 150 | Decreased central vision (HP:0007663) | 1.78574677 |
| 151 | Glomerulonephritis (HP:0000099) | 1.78545227 |
| 152 | Onion bulb formation (HP:0003383) | 1.78010901 |
| 153 | Keratoconjunctivitis sicca (HP:0001097) | 1.77854628 |
| 154 | Iris hypopigmentation (HP:0007730) | 1.77467808 |
| 155 | Pustule (HP:0200039) | 1.77105599 |
| 156 | Abnormality of macular pigmentation (HP:0008002) | 1.76412494 |
| 157 | T lymphocytopenia (HP:0005403) | 1.76060249 |
| 158 | Generalized hypopigmentation of hair (HP:0011358) | 1.75652143 |
| 159 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.75326869 |
| 160 | Prolonged QT interval (HP:0001657) | 1.75321296 |
| 161 | Bradykinesia (HP:0002067) | 1.74953663 |
| 162 | Increased serum ferritin (HP:0003281) | 1.74643133 |
| 163 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.74543713 |
| 164 | Lower limb amyotrophy (HP:0007210) | 1.73092545 |
| 165 | Gait ataxia (HP:0002066) | 1.72586460 |
| 166 | Vaginal atresia (HP:0000148) | 1.71948073 |
| 167 | Steppage gait (HP:0003376) | 1.71893495 |
| 168 | Lower limb muscle weakness (HP:0007340) | 1.69997168 |
| 169 | EEG with generalized epileptiform discharges (HP:0011198) | 1.69683062 |
| 170 | Spinal canal stenosis (HP:0003416) | 1.69673797 |
| 171 | Horizontal nystagmus (HP:0000666) | 1.69538278 |
| 172 | Abnormality of saccadic eye movements (HP:0000570) | 1.68391975 |
| 173 | Pointed chin (HP:0000307) | 1.67732355 |
| 174 | Hypothermia (HP:0002045) | 1.66888188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.53880249 |
| 2 | NTRK3 | 4.42106706 |
| 3 | CASK | 3.28958991 |
| 4 | RIPK1 | 2.86284017 |
| 5 | MAP2K7 | 2.72315404 |
| 6 | MAP3K9 | 2.72222378 |
| 7 | MAP3K4 | 2.56512408 |
| 8 | TNIK | 2.55134125 |
| 9 | RIPK4 | 2.48210321 |
| 10 | IRAK3 | 2.44233564 |
| 11 | DAPK2 | 2.43811901 |
| 12 | MINK1 | 2.36481841 |
| 13 | MAP4K1 | 2.24429787 |
| 14 | MAP3K11 | 2.01948523 |
| 15 | ERN1 | 2.00139240 |
| 16 | PRPF4B | 1.99460009 |
| 17 | MARK1 | 1.99115542 |
| 18 | NTRK2 | 1.92542560 |
| 19 | TAOK2 | 1.80678184 |
| 20 | TRIB3 | 1.78394410 |
| 21 | PAK6 | 1.77133916 |
| 22 | MAPK13 | 1.62520317 |
| 23 | BMPR2 | 1.59159612 |
| 24 | SIK2 | 1.55449194 |
| 25 | MAP3K12 | 1.53544386 |
| 26 | FES | 1.52174567 |
| 27 | NTRK1 | 1.51347307 |
| 28 | TYK2 | 1.49403400 |
| 29 | TBK1 | 1.45106400 |
| 30 | SGK2 | 1.42843339 |
| 31 | CAMKK1 | 1.41099043 |
| 32 | PNCK | 1.39645576 |
| 33 | SGK494 | 1.38483109 |
| 34 | SGK223 | 1.38483109 |
| 35 | CDK5 | 1.38188664 |
| 36 | CAMKK2 | 1.37087105 |
| 37 | MAP3K14 | 1.34874877 |
| 38 | MAP3K3 | 1.34567369 |
| 39 | KSR2 | 1.34211930 |
| 40 | GRK5 | 1.33561090 |
| 41 | MAP2K4 | 1.33037884 |
| 42 | PLK2 | 1.32762214 |
| 43 | TESK1 | 1.32414743 |
| 44 | ZAP70 | 1.29525605 |
| 45 | TNK2 | 1.29366118 |
| 46 | DDR2 | 1.28752933 |
| 47 | TAOK1 | 1.25664097 |
| 48 | MAP3K13 | 1.23903878 |
| 49 | MAP2K3 | 1.23280399 |
| 50 | CSK | 1.22528477 |
| 51 | NEK6 | 1.21494146 |
| 52 | NME2 | 1.19759694 |
| 53 | DAPK1 | 1.19644006 |
| 54 | ICK | 1.16710496 |
| 55 | JAK1 | 1.15274071 |
| 56 | PRKCG | 1.14844071 |
| 57 | STK38 | 1.14293918 |
| 58 | CDK19 | 1.10499645 |
| 59 | WNK1 | 1.08501562 |
| 60 | SIK1 | 1.06662932 |
| 61 | MOS | 1.06421400 |
| 62 | KSR1 | 1.06002077 |
| 63 | ARAF | 1.05789047 |
| 64 | PRKD3 | 1.00848777 |
| 65 | CAMK1 | 1.00749038 |
| 66 | OXSR1 | 0.99885326 |
| 67 | SIK3 | 0.99624912 |
| 68 | IKBKE | 0.95139237 |
| 69 | MAPK12 | 0.93980123 |
| 70 | CAMK2A | 0.93776701 |
| 71 | SGK3 | 0.92640172 |
| 72 | EPHB1 | 0.91936034 |
| 73 | AKT3 | 0.91791904 |
| 74 | PINK1 | 0.90376549 |
| 75 | MAP3K2 | 0.88984745 |
| 76 | TGFBR2 | 0.85975345 |
| 77 | MAP2K6 | 0.85725264 |
| 78 | CAMK2B | 0.85472359 |
| 79 | TXK | 0.84069561 |
| 80 | ADRBK2 | 0.83737572 |
| 81 | UHMK1 | 0.82332748 |
| 82 | SGK1 | 0.81536773 |
| 83 | HIPK2 | 0.80515290 |
| 84 | JAK2 | 0.79974126 |
| 85 | STK11 | 0.78277242 |
| 86 | DYRK1A | 0.78138792 |
| 87 | JAK3 | 0.77916453 |
| 88 | IRAK2 | 0.76704080 |
| 89 | PRKG2 | 0.76265178 |
| 90 | IRAK4 | 0.74906046 |
| 91 | PRKCH | 0.73765676 |
| 92 | FGR | 0.73053963 |
| 93 | LMTK2 | 0.71943673 |
| 94 | CDK18 | 0.71349749 |
| 95 | SYK | 0.69359486 |
| 96 | GRK6 | 0.68063043 |
| 97 | MARK2 | 0.67821177 |
| 98 | IKBKB | 0.67689118 |
| 99 | PRKCE | 0.67071499 |
| 100 | CDK15 | 0.66929507 |
| 101 | GRK1 | 0.66691645 |
| 102 | PKN1 | 0.60810692 |
| 103 | PTK2B | 0.60050209 |
| 104 | CDC42BPA | 0.59385916 |
| 105 | LATS2 | 0.59107034 |
| 106 | HCK | 0.58889243 |
| 107 | CDK14 | 0.58844885 |
| 108 | CDK11A | 0.58268790 |
| 109 | BRAF | 0.57541635 |
| 110 | PDPK1 | 0.57220466 |
| 111 | TTN | 0.56749981 |
| 112 | PDK1 | 0.56435405 |
| 113 | PHKG1 | 0.55427995 |
| 114 | PHKG2 | 0.55427995 |
| 115 | ITK | 0.55250625 |
| 116 | LCK | 0.54830673 |
| 117 | BMX | 0.53668518 |
| 118 | PTK6 | 0.52937909 |
| 119 | CDK3 | 0.52573320 |
| 120 | BTK | 0.51993061 |
| 121 | CAMK4 | 0.51975745 |
| 122 | CAMK2D | 0.51756609 |
| 123 | TYRO3 | 0.50656234 |
| 124 | YES1 | 0.50190434 |
| 125 | GRK7 | 0.49769631 |
| 126 | CCNB1 | 0.49718026 |
| 127 | TESK2 | 0.48627117 |
| 128 | PRKD2 | 0.48297046 |
| 129 | RET | 0.47732358 |
| 130 | CAMK2G | 0.47535294 |
| 131 | FGFR4 | 0.46771291 |
| 132 | FYN | 0.46756408 |
| 133 | RPS6KA2 | 0.46562450 |
| 134 | PIM2 | 0.45614397 |
| 135 | MST1R | 0.45147983 |
| 136 | RAF1 | 0.43898058 |
| 137 | ABL2 | 0.42591189 |
| 138 | RPS6KA3 | 0.42374789 |
| 139 | ADRBK1 | 0.40916287 |
| 140 | CSNK1A1 | 0.40278146 |
| 141 | MAP3K1 | 0.40271865 |
| 142 | PRKACA | 0.39809143 |
| 143 | MAPK10 | 0.39253362 |
| 144 | STK39 | 0.39194359 |
| 145 | BLK | 0.39179900 |
| 146 | MAPK7 | 0.39013153 |
| 147 | CAMK1G | 0.37934748 |
| 148 | PRKCB | 0.37730372 |
| 149 | MAPKAPK5 | 0.37589275 |
| 150 | PRKCZ | 0.37552480 |
| 151 | PRKG1 | 0.37292277 |
| 152 | INSRR | 0.36180189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.99460126 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.12394202 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.98191491 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.85761252 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.79637094 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.73655810 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.70052201 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.61223311 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.43932094 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.41944236 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 2.31553527 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.31019219 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.30629068 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.17089519 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10439290 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.02227646 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 2.00699133 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.90133601 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.89962164 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.81470377 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.78356045 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.74324580 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.73948009 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.72788188 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68538700 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.67606280 |
| 27 | Lysosome_Homo sapiens_hsa04142 | 1.63085844 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.57236924 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.56510739 |
| 30 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.55864730 |
| 31 | Cocaine addiction_Homo sapiens_hsa05030 | 1.55732188 |
| 32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.54204922 |
| 33 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.45816012 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.45172904 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43813238 |
| 36 | Leishmaniasis_Homo sapiens_hsa05140 | 1.41860734 |
| 37 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.41558670 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.38926525 |
| 39 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36489150 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.33093047 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32488506 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32324376 |
| 43 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.31494667 |
| 44 | Allograft rejection_Homo sapiens_hsa05330 | 1.30477632 |
| 45 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30324179 |
| 46 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29037186 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.28756414 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.19256639 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.17142101 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 1.16540315 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15621381 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12065565 |
| 53 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11673952 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09892136 |
| 55 | Malaria_Homo sapiens_hsa05144 | 1.09653855 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07064477 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.04807303 |
| 58 | Axon guidance_Homo sapiens_hsa04360 | 1.03823356 |
| 59 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.03519635 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00531864 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99273939 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96946425 |
| 63 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95647350 |
| 64 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93916203 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92126983 |
| 66 | Melanogenesis_Homo sapiens_hsa04916 | 0.90488781 |
| 67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89811398 |
| 68 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89631084 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89044852 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.88331822 |
| 71 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87718641 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.86503686 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.85870336 |
| 74 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.85062250 |
| 75 | Glioma_Homo sapiens_hsa05214 | 0.84710538 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84132542 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.81950255 |
| 78 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.80857632 |
| 79 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79851570 |
| 80 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79132826 |
| 81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78879809 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75576086 |
| 83 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74723892 |
| 84 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73876772 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73234341 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73006062 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72914389 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72586498 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.71685347 |
| 90 | Measles_Homo sapiens_hsa05162 | 0.65988679 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.65601538 |
| 92 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64006858 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.63970251 |
| 94 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.63517059 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62700241 |
| 96 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.62591946 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61852355 |
| 98 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.61045064 |
| 99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60871000 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60425162 |
| 101 | Amoebiasis_Homo sapiens_hsa05146 | 0.59716429 |
| 102 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59426518 |
| 103 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.58788992 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.58662931 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.58590354 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58515947 |
| 107 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.57822348 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.56870998 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55999953 |
| 110 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55942718 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55760007 |
| 112 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55382833 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55232833 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52014879 |
| 115 | Circadian rhythm_Homo sapiens_hsa04710 | 0.51429020 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.50645452 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46998126 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45294768 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44985381 |
| 120 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44251895 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42811991 |
| 122 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.42133487 |
| 123 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.41697705 |
| 124 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40870781 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40081207 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39741697 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39261435 |
| 128 | Mineral absorption_Homo sapiens_hsa04978 | 0.39014585 |
| 129 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36594169 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.35253392 |
| 131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33859947 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.33786585 |
| 133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32193928 |
| 134 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31206136 |
| 135 | Melanoma_Homo sapiens_hsa05218 | 0.29142516 |
| 136 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.28958864 |
| 137 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26690903 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24676287 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24333218 |
| 140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24060052 |
| 141 | Salmonella infection_Homo sapiens_hsa05132 | 0.22975745 |
| 142 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22678549 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.20899075 |

